Skip to main content
. 2013 Dec 1;6(6):660–669. doi: 10.1593/tlo.13559

Figure 1.

Figure 1

Effect of antiangiogenic treatment in U251 tumor determined by MRI. Postcontrast T1WI (A) and T2WI changes (B) after 2 weeks of antiangiogenic treatment with vatalanib, sunitinib, and AMD3100; tumor volumes measured after vehicle and drug treatment (C); T2 maps of U251 tumors following antiangiogenic therapy showed no significant edema or necrosis compared to the vehicle-treated tumor (D). *P < .05. All tumors were in the right hemisphere.